Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study

Overview

Journal J Pers Med

Date 2021 Jun 2

PMID 34066838

Citations 4

Authors

Giacomo Santandrea

Chiara Bellarosa

Dino Gibertoni

Maria C Cucchi

Alejandro M Sanchez

Gianluca Franceschini

Riccardo Masetti

Maria P Foschini

Affiliations

Soon will be listed here.

Abstract

Normal breast tissue undergoes great variations during a woman's life as a consequence of the different hormonal stimulation. The purpose of the present study was to examine the hormonal receptor expression variations according to age, menstrual cycle, menopausal state and body mass index. To this purpose, 49 tissue samples of normal breast tissue, obtained during surgery performed for benign and malignant conditions, were immunostained with Estrogen (ER), Progesterone (PR) and Androgen receptors (AR). In addition, Ki67 and Gross Cystic Disease Fluid Protein were studied. The data obtained revealed a great variability of hormone receptor expression. ER and AR generally increased in older and post-menopausal women, while young women presented a higher proliferative rate, evaluated with Ki67. PR increase was observed in women with BMI higher than 25. The different hormonal receptor expression could favor the development of breast cancer.

Citing Articles

Lactating Adenoma Arising From Ovarian Mature Teratoma: An Unusual Presentation of a Young Pregnant Woman.

Thirugnanasambandan S, Amitkumar K, Sudalaimuthu M Cureus. 2024; 16(7):e65846.

PMID: 39219914 PMC: 11363880. DOI: 10.7759/cureus.65846.

Design and synthesis of phosphoryl-substituted steroidal pyridazines (Pho-STPYRs) as potent estrogen receptor alpha inhibitors: targeted treatment of hormone-dependent breast cancer cells.

Volkova Y, Scherbakov A, Dzichenka Y, Komkov A, Bogdanov F, Salnikova D RSC Med Chem. 2024; 15(7):2380-2399.

PMID: 39026643 PMC: 11253874. DOI: 10.1039/d4md00153b.

The relationship between night shift work and breast cancer incidence: A systematic review and meta-analysis of observational studies.

Hong J, He Y, Fu R, Si Y, Xu B, Xu J Open Med (Wars). 2022; 17(1):712-731.

PMID: 35702390 PMC: 8995855. DOI: 10.1515/med-2022-0470.

Innovations in the Integrated Management of Breast Cancer.

Franceschini G, Sanchez A, Mason E, Masetti R J Pers Med. 2022; 12(4).

PMID: 35455647 PMC: 9032921. DOI: 10.3390/jpm12040531.

References

Daly A, Rolph R, Cutress R, Copson E . A Review of Modifiable Risk Factors in Young Women for the Prevention of Breast Cancer. Breast Cancer (Dove Med Press). 2021; 13:241-257. PMC: 8053601. DOI: 10.2147/BCTT.S268401. View

Santisteban M, Reynolds C, Barr Fritcher E, Frost M, Vierkant R, Anderson S . Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia. Breast Cancer Res Treat. 2009; 121(2):431-7. PMC: 2890280. DOI: 10.1007/s10549-009-0534-7. View

Zimpfer A, Schonberg S, Lugli A, Agostinelli C, Pileri S, Went P . Construction and validation of a bone marrow tissue microarray. J Clin Pathol. 2006; 60(1):57-61. PMC: 1860588. DOI: 10.1136/jcp.2005.035758. View

Tot T . The theory of the sick breast lobe and the possible consequences. Int J Surg Pathol. 2007; 15(4):369-75. DOI: 10.1177/1066896907302225. View

Khan S, Rogers M, Khurana K, Meguid M, Numann P . Estrogen receptor expression in benign breast epithelium and breast cancer risk. J Natl Cancer Inst. 1998; 90(1):37-42. DOI: 10.1093/jnci/90.1.37. View

Munsell M, Sprague B, Berry D, Chisholm G, Trentham-Dietz A . Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2013; 36:114-36. PMC: 3873844. DOI: 10.1093/epirev/mxt010. View

Eiriz I, Vaz Batista M, Cruz Tomas T, Neves M, Guerra-Pereira N, Braga S . Breast cancer in very young women-a multicenter 10-year experience. ESMO Open. 2021; 6(1):100029. PMC: 7807935. DOI: 10.1016/j.esmoop.2020.100029. View

McNamara K, Yoda T, Takagi K, Miki Y, Suzuki T, Sasano H . Androgen receptor in triple negative breast cancer. J Steroid Biochem Mol Biol. 2012; 133:66-76. DOI: 10.1016/j.jsbmb.2012.08.007. View

Lydon J, Ge G, Kittrell F, Medina D, OMalley B . Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function. Cancer Res. 1999; 59(17):4276-84. View

10.

Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Irani A . Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One. 2012; 7(12):e51446. PMC: 3517558. DOI: 10.1371/journal.pone.0051446. View

11.

Battersby S, Robertson B, Anderson T, King R, McPherson K . Influence of menstrual cycle, parity and oral contraceptive use on steroid hormone receptors in normal breast. Br J Cancer. 1992; 65(4):601-7. PMC: 1977560. DOI: 10.1038/bjc.1992.122. View

12.

Lawson J, Field A, Tran D, Houssami N . Hormone replacement therapy use dramatically increases breast oestrogen receptor expression in obese postmenopausal women. Breast Cancer Res. 2001; 3(5):342-5. PMC: 57804. DOI: 10.1186/bcr318. View

13.

Tot T . DCIS, cytokeratins, and the theory of the sick lobe. Virchows Arch. 2005; 447(1):1-8. DOI: 10.1007/s00428-005-1274-7. View

14.

Cremonini A, Saragoni L, Morandi L, Corradini A, Ravaioli C, Di Oto E . Chromosome X aneusomy and androgen receptor gene copy number aberrations in apocrine carcinoma of the breast. Virchows Arch. 2021; 479(2):345-354. PMC: 8364532. DOI: 10.1007/s00428-021-03028-2. View

15.

Huh S, Oh H, Peterson M, Almendro V, Hu R, Bowden M . The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal Women. Cancer Res. 2016; 76(7):1926-34. PMC: 4873436. DOI: 10.1158/0008-5472.CAN-15-1927. View

16.

Saha S, Dey S, Nath S . Steroid Hormone Receptors: Links With Cell Cycle Machinery and Breast Cancer Progression. Front Oncol. 2021; 11:620214. PMC: 7994514. DOI: 10.3389/fonc.2021.620214. View

17.

Acheampong T, Kehm R, Terry M, Argov E, Tehranifar P . Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016. JAMA Netw Open. 2020; 3(8):e2013226. PMC: 7431997. DOI: 10.1001/jamanetworkopen.2020.13226. View

18.

Tamimi R, Colditz G, Wang Y, Collins L, Hu R, Rosner B . Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011; 128(1):243-50. PMC: 3116083. DOI: 10.1007/s10549-010-1313-1. View

19.

Longacre T, Bartow S . A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol. 1986; 10(6):382-93. DOI: 10.1097/00000478-198606000-00003. View

20.

Maisonneuve P, Disalvatore D, Rotmensz N, Curigliano G, Colleoni M, Dellapasqua S . Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes. Breast Cancer Res. 2014; 16(3):R65. PMC: 4095689. DOI: 10.1186/bcr3679. View